Adalimumab (Systemic)

Category

• Rheumatoid arthritis

Description

Adalimumab (ADD-ah-lim-u-mab) is used to decreased signs, symptoms, and progression of moderately to severely active rheumatoid arthritis. It is intended for use in patients who have not responded well to other Disease Modifying Antirheumatic Drugs (DMARDS). Adalimumab can be used in combination with methotrexate or other DMARD's.

This medicine is available only with your doctor's prescription, in the following dosage forms:

Parenteral
• Injection (U.S.)

Brand Names

Some commonly used brand names are:

In the U.S. -

• Adalimumab

Generic name product may be available in the U.S.

† Not commercially available in Canada.